Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era. | Biomedicines | 2022 | 36009473 | PubTator, text mining | PubMed |
| Structure-Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria Toxin. | Biomolecules | 2022 | 36009005 | PubTator, text mining | PubMed |
| Current understanding of the human microbiome in glioma. | Front Oncol | 2022 | 36003766 | PubTator, text mining | PubMed |
| Development of Nodular Lesions after Dupilumab Therapy in Erythrodermic Mycosis Fungoides with Interleukin-13 Receptor alpha2 Expression. | Acta Derm Venereol | 2022 | 36000994 | PubTator, text mining | PubMed |
| The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases. | Adv Ther | 2022 | 35997892 | PubTator, text mining | PubMed |
| STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges. | Semin Cancer Biol | 2022 | 35995341 | PubTator, text mining | PubMed |
| Exosome-based strategies for diagnosis and therapy of glioma cancer. | Cancer Cell Int | 2022 | 35989351 | PubTator, text mining | PubMed |
| Pathogenic role of monocytes/macrophages in large vessel vasculitis. | Front Immunol | 2022 | 35967455 | PubTator, text mining | PubMed |
| Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma. | Neurooncol Adv | 2022 | 35967100 | PubTator, text mining | PubMed |
| Investigation on Probable Association Between IL-13, IL-13RA1, and IL-13RA2 Genes Polymorphism and Pulmonary Tuberculosis. | J Inflamm Res | 2022 | 35966004 | PubTator, text mining | PubMed |
| Editorial: Cytokine and cytokine receptor-based immunotherapies: Updates, controversies, challenges, and future perspectives. | Front Immunol | 2022 | 35958607 | PubTator, text mining | PubMed |
| Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy. | Front Oncol | 2022 | 35957898 | PubTator, text mining | PubMed |
| The metabolic addiction of cancer stem cells. | Front Oncol | 2022 | 35957877 | PubTator, text mining | PubMed |
| Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy. | Cancers (Basel) | 2022 | 35954362 | PubTator, text mining | PubMed |
| Chitinase 3 like 1 contributes to the development of pulmonary vascular remodeling in pulmonary hypertension. | JCI Insight | 2022 | 35951428 | PubTator, text mining | PubMed |
| Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy. | Proc Natl Acad Sci U S A | 2022 | 35939683 | PubTator, text mining | PubMed |
| CAR T Cells: Cancer Cell Surface Receptors Are the Target for Cancer Therapy. | Adv Pharm Bull | 2022 | 35935042 | PubTator, text mining | PubMed |
| Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease. | J Allergy Clin Immunol | 2022 | 35934680 | PubTator, text mining | PubMed |
| shRNA‑mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8. | Cell Death Dis | 2022 | 35933405 | PubTator, text mining | PubMed |
| Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective. | Antib Ther | 2022 | 35928456 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=35